ProQR Therapeutics (PRQR) Analyst & Key Data

Analyst Consensus

Analyst recommendation mix is not available yet.

Total Analysts1

Ratings

Updated Sep 12, 2026

Overall Rating

C+

DCF Score4.0 / 5

Debt / Equity Score3.0 / 5

Price / Book Score3.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$1.86

Median Target+61.29%

$3.00

Potential upside vs current price

Current Stock Price

$1.86

Median Target+61.29%

$3.00

Potential upside vs current price

Analyst Consensus

Analyst recommendation mix is not available yet.

Total Analysts1

Ratings

Updated Sep 12, 2026

Overall Rating

C+

DCF Score4.0 / 5

Debt / Equity Score3.0 / 5

Price / Book Score3.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$1.86

Median Target+61.29%

$3.00

Potential upside vs current price

Current Stock Price

$1.86

Median Target+61.29%

$3.00

Potential upside vs current price

ProQR Therapeutics N.V.